![At a meeting organised by the European Molecular Biology Laboratory [EMBL] in Heidelberg, Germany, scientists from around the globe announced the formation of the International Human Microbiome ......](/img/logo_new.gif){kind=logo}
PREVIEW
OF YOUR NEWS WIDGETPharmaceuticals news and pharmaceuticals widget
Sunday, October 19, 2008 ( change date )
Biotec Pharmacon: Patient inclusion started in phase III Oral Mucositis study
Patient inclusion has commenced as planned in the first of two phase III studies for the use of Biotec Pharmacon's SBG in patients with oral mucositis. This is a common and potentially severe ...
bionity.com Sunday, October 19, 2008Cell Genesys Announces Termination of VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Cell Genesys, Inc. announced its decision to terminate the VITAL-1 Phase 3 clinical trial of GVAX immunotherapy in patients with asymptomatic metastatic hormone-refractory prostate cancer. The trial ...
bionity.com Sunday, October 19, 2008Epigenomics AG Reports Successful Completion and Positive Results from Prostate Cancer Clinical Study
Epigenomics AG reported positive final results from its prognostic prostate cancer study."After testing all patient samples for methylation in the PITX2 gene we have successfully conducted our final ...
bionity.com Sunday, October 19, 2008Researchers establish international human microbiome consortium
At a meeting organised by the European Molecular Biology Laboratory [EMBL] in Heidelberg, Germany, scientists from around the globe announced the formation of the International Human Microbiome ...
bionity.com Sunday, October 19, 2008
INSTALL YOUR WIDGET